InsiderFlow

Terrie Curran

PHAT

Terrie Curran serves as Director at Phathom Pharmaceuticals, Inc. (PHAT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$252.9K

Total Sells

7 trades

$1.22M

Net Position

Net Seller

$965.0K

Companies Traded

2

ARQT, PHAT

Active Period

Mar 2021 – Nov 2024

9 total trades

Most Recent

Sell ARQT

Nov 11, 2024 · $94.2K

Terrie Curran's Insider Trading at Phathom Pharmaceuticals, Inc. (PHAT)

Buys

2 · $252.9K

Sells

6 · $1.12M

Total Shares Bought

33,419

Total Shares Sold

70,995

PHAT Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Jul 17, 2024Sell33,848$11.72$396.7K377,734
Mar 26, 2024Sell16,851$9.11$153.5K410,784
Apr 7, 2023Buy12,919$7.82$101.0K188,290
Mar 3, 2023Sell1,436$8.54$12.3K175,371
Jan 20, 2023Sell5,821$8.20$47.7K176,807
Nov 23, 2022Sell1,526$9.60$14.6K83,720
May 16, 2022Buy20,500$7.41$151.8K64,595
Mar 23, 2021Sell11,513$43.32$498.8K1,140

Terrie Curran's Insider Trading at Arcutis Biotherapeutics, Inc. (ARQT)

Buys

0 · $0.00

Sells

1 · $94.2K

Total Shares Bought

0

Total Shares Sold

8,687

ARQT Price Chart
Loading chart...
DateTypeSharesAvg PriceValueShares After
Nov 11, 2024Sell8,687$10.85$94.2K0